- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.39 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 8UM: 5-[(5S)-5-ethyl-5-methyl-6-oxo-1,4,5,6-tetrahydropyridin-3-yl]-N-(6-fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)thiophene-2-sulfonamide(Non-covalent)
- 4 x AMZ: AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE(Non-covalent)
AMZ.2: 15 residues within 4Å:- Chain A: N.440, R.460, A.549, F.550, R.597, F.599
- Chain B: R.216, Y.217, I.247, N.248, K.275, H.276, G.325, D.348
- Ligands: 8UM.5
12 PLIP interactions:6 interactions with chain A, 6 interactions with chain B- Hydrogen bonds: A:N.440, A:N.440, A:R.460, A:F.550, B:N.248, B:D.348
- Salt bridges: A:R.597, B:R.216
- pi-Stacking: A:F.599
- Water bridges: B:R.216, B:I.247, B:N.248
AMZ.3: 21 residues within 4Å:- Chain A: S.19, V.20, S.21, K.23, S.43, G.44, G.45, T.46, G.72, R.73, V.74, K.75, T.76, L.77, C.110, N.111, L.112, Y.113, D.134, G.136, G.137
16 PLIP interactions:16 interactions with chain A- Hydrogen bonds: A:V.20, A:S.43, A:G.45, A:T.46, A:T.46, A:T.46, A:G.72, A:R.73, A:K.75, A:T.76, A:L.77, A:N.111, A:D.134, A:G.136
- Salt bridges: A:K.23, A:K.75
AMZ.6: 15 residues within 4Å:- Chain A: R.216, Y.217, I.247, N.248, K.275, H.276, G.325, D.348
- Chain B: N.440, R.460, A.549, F.550, R.597, F.599
- Ligands: 8UM.1
11 PLIP interactions:6 interactions with chain A, 5 interactions with chain B- Hydrogen bonds: A:N.248, A:H.276, A:D.348, B:N.440, B:R.460, B:F.550
- Water bridges: A:R.216, A:R.216
- Salt bridges: A:R.216, B:R.597
- pi-Stacking: B:F.599
AMZ.7: 19 residues within 4Å:- Chain B: S.19, V.20, S.21, K.23, S.43, G.44, G.45, T.46, R.73, V.74, K.75, T.76, L.77, C.110, N.111, Y.113, D.134, G.136, G.137
19 PLIP interactions:19 interactions with chain B- Hydrogen bonds: B:S.19, B:G.44, B:G.45, B:T.46, B:T.46, B:R.73, B:K.75, B:T.76, B:L.77, B:N.111, B:Y.113, B:Y.113, B:D.134, B:G.136
- Water bridges: B:I.135, B:I.135
- Salt bridges: B:K.23, B:K.75
- pi-Cation interactions: B:K.75
- 2 x MG: MAGNESIUM ION(Non-covalent)
MG.4: 7 residues within 4Å:- Chain A: V.434, T.437, S.439, S.441, D.548, L.598, H.600
4 PLIP interactions:4 interactions with chain A- Metal complexes: A:V.434, A:T.437, A:D.548, A:L.598
MG.8: 7 residues within 4Å:- Chain B: V.434, T.437, S.439, S.441, D.548, L.598, H.600
4 PLIP interactions:4 interactions with chain B- Metal complexes: B:V.434, B:T.437, B:D.548, B:L.598
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fales, K.R. et al., Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model. J. Med. Chem. (2017)
- Release Date
- 2018-01-10
- Peptides
- Bifunctional purine biosynthesis protein PURH: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.39 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 8UM: 5-[(5S)-5-ethyl-5-methyl-6-oxo-1,4,5,6-tetrahydropyridin-3-yl]-N-(6-fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)thiophene-2-sulfonamide(Non-covalent)
- 4 x AMZ: AMINOIMIDAZOLE 4-CARBOXAMIDE RIBONUCLEOTIDE(Non-covalent)
- 2 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fales, K.R. et al., Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model. J. Med. Chem. (2017)
- Release Date
- 2018-01-10
- Peptides
- Bifunctional purine biosynthesis protein PURH: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
CB
D